Skip to main content

Raleigh Capital Management Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 1911726 CARY, NC

Position in GILD

as of Jun 30, 2026 · filed Jul 21, 2026
Position Value
$254,827
-$27,536 QoQ
Shares Held
2,017
-0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,768
of 2,265 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Raleigh Capital Management Inc. holds $16,702,583 across 11 Drug Manufacturers - General names. GILD ranks #8 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 GILD
Gilead Sciences, Inc.
This page
2,017 $254,827

All Filings in GILD

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $254,827 2,017
2026-03-31 $282,363 2,026
2025-12-31 $1,060,473 8,640
2025-09-30 $1,127,760 10,160
2025-06-30 $1,421,353 12,820
2025-03-31 $2,144,076 19,135
2024-12-31 $2,788,003 30,183
2024-09-30 $2,783,236 33,197
2024-06-30 $1,742,419 25,396
2024-03-31 $1,768,841 24,148
2023-12-31 $1,585,526 19,572
2023-09-30 $1,496,401 19,968
2023-06-30 $1,373,387 17,820
2023-03-31 $2,269,063 27,348
2022-12-31 $3,991,767 46,497
2022-09-30 $3,110,470 50,421
2022-06-30 $2,489,767 40,281
2022-03-31 $1,621,082 27,268
2021-12-31 $5,373 74